Clinical Trial Update: Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors

View source ↗

Summary

This trial update reports results from the DREAM study comparing semaglutide and DPP-4 inhibitors for Alzheimer's medicines, based on data analysis. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Diabetes Mellitus

Drugs mentioned

• DPP-4 inhibitors (class)
• semaglutide (semaglutide)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Diabetes | Status: COMPLETED | Results posted: 2025-11-10